EP 4157453 A4 20240619 - METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH LEVOCABASTINE, A SELECTIVE HISTAMINE H1-RECEPTOR ANTAGONIST, AND DERIVATIVES THEREOF
Title (en)
METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH LEVOCABASTINE, A SELECTIVE HISTAMINE H1-RECEPTOR ANTAGONIST, AND DERIVATIVES THEREOF
Title (de)
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR PRÄVENTION UND BEHANDLUNG VON MYOPIE MIT LEVOCABASTIN, EINEM SELEKTIVEN HISTAMIN-H1-REZEPTORANTAGONISTEN UND DERIVATEN DAVON
Title (fr)
MÉTHODES ET COMPOSITIONS POUR LA PRÉVENTION ET LE TRAITEMENT DE LA MYOPIE AVEC DE LA LÉVOCABASTINE, UN ANTAGONISTE SÉLECTIF DU RÉCEPTEUR H1 DE L'HISTAMINE ET DES DÉRIVÉS DE CELUI-CI
Publication
Application
Priority
- US 202063033291 P 20200602
- US 2021035344 W 20210602
Abstract (en)
[origin: WO2021247635A1] The disclosure relates to methods and compositions for preventing and/or treating an ocular disease. In particular, the disclosure relates to preventing and/or treating myopia with systemic or topical administration of levocabastine hydrochloride, which is a selective histamine HI -receptor antagonist, or a derivative thereof.
IPC 8 full level
A61K 31/451 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/19 (2006.01); A61K 31/445 (2006.01); A61P 27/02 (2006.01); A61P 27/10 (2006.01); C07C 255/60 (2006.01)
CPC (source: EP IL KR)
A61K 9/0048 (2013.01 - EP); A61K 9/0051 (2013.01 - KR); A61K 9/0053 (2013.01 - EP IL); A61K 31/451 (2013.01 - EP IL KR); A61P 27/02 (2018.01 - EP IL); A61P 27/10 (2018.01 - EP IL KR)
Citation (search report)
- [A] WO 2019104191 A1 20190531 - SYDNEXIS INC [US]
- [A] WO 2017140846 A1 20170824 - D'AMBROSIO ENZO MARIA [IT]
- See also references of WO 2021247635A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021247635 A1 20211209; CA 3181292 A1 20211209; CN 115835905 A 20230321; EP 4157453 A1 20230405; EP 4157453 A4 20240619; IL 298796 A 20230201; JP 2023529374 A 20230710; KR 20230051130 A 20230417
DOCDB simple family (application)
US 2021035344 W 20210602; CA 3181292 A 20210602; CN 202180049465 A 20210602; EP 21816939 A 20210602; IL 29879622 A 20221204; JP 2022574559 A 20210602; KR 20227046225 A 20210602